Cargando…

The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis

Fibrosis is considered a complex form of tissue damage commonly present in the end stage of many diseases. It is also related to a high percentage of death, whose predominant characteristics are an excessive and abnormal deposition of fibroblasts and myofibroblasts -derived extracellular matrix (ECM...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyaseer, Amani Abraheem Alsadiq, de Lima, Murilo Henrique Saturnino, Braga, Tarcio Teodoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251178/
https://www.ncbi.nlm.nih.gov/pubmed/32508821
http://dx.doi.org/10.3389/fimmu.2020.00883
_version_ 1783538911029493760
author Alyaseer, Amani Abraheem Alsadiq
de Lima, Murilo Henrique Saturnino
Braga, Tarcio Teodoro
author_facet Alyaseer, Amani Abraheem Alsadiq
de Lima, Murilo Henrique Saturnino
Braga, Tarcio Teodoro
author_sort Alyaseer, Amani Abraheem Alsadiq
collection PubMed
description Fibrosis is considered a complex form of tissue damage commonly present in the end stage of many diseases. It is also related to a high percentage of death, whose predominant characteristics are an excessive and abnormal deposition of fibroblasts and myofibroblasts -derived extracellular matrix (ECM) components. Epithelial-to-mesenchymal transition (EMT), a process in which epithelial cells gradually change to mesenchymal ones, is a major contributor in the pathogenesis of fibrosis. The key mediator of EMT is a multifunctional cytokine called transforming growth factor-β (TGF-β) that acts as the main inducer of the ECM assembly and remodeling through the phosphorylation of Smad2/3, which ultimately forms a complex with Smad4 and translocates into the nucleus. On the other hand, the bone morphogenic protein-7 (BMP-7), a member of the TGF family, reverses EMT by directly counteracting TGF-β induced Smad-dependent cell signaling. NLRP3 (NACHT, LRR, and PYD domains-containing protein 3), in turn, acts as cytosolic sensors of microbial and self-derived molecules and forms an immune complex called inflammasome in the context of inflammatory commitments. NLRP3 inflammasome assembly is triggered by extracellular ATP, reactive oxygen species (ROS), potassium efflux, calcium misbalance, and lysosome disruption. Due to its involvement in multiple diseases, NLRP3 has become one of the most studied pattern-recognition receptors (PRRs). Nevertheless, the role of NLRP3 in fibrosis development has not been completely elucidated. In this review, we described the relation of the previously mentioned fibrosis pathway with the NLRP3 inflammasome complex formation, especially EMT-related pathways. For now, it is suggested that the EMT happens independently from the oligomerization of the whole inflammasome complex, requiring just the presence of the NLRP3 receptor and the ASC protein to trigger the EMT events, and we will present different pieces of research that give controversial point of views.
format Online
Article
Text
id pubmed-7251178
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72511782020-06-05 The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis Alyaseer, Amani Abraheem Alsadiq de Lima, Murilo Henrique Saturnino Braga, Tarcio Teodoro Front Immunol Immunology Fibrosis is considered a complex form of tissue damage commonly present in the end stage of many diseases. It is also related to a high percentage of death, whose predominant characteristics are an excessive and abnormal deposition of fibroblasts and myofibroblasts -derived extracellular matrix (ECM) components. Epithelial-to-mesenchymal transition (EMT), a process in which epithelial cells gradually change to mesenchymal ones, is a major contributor in the pathogenesis of fibrosis. The key mediator of EMT is a multifunctional cytokine called transforming growth factor-β (TGF-β) that acts as the main inducer of the ECM assembly and remodeling through the phosphorylation of Smad2/3, which ultimately forms a complex with Smad4 and translocates into the nucleus. On the other hand, the bone morphogenic protein-7 (BMP-7), a member of the TGF family, reverses EMT by directly counteracting TGF-β induced Smad-dependent cell signaling. NLRP3 (NACHT, LRR, and PYD domains-containing protein 3), in turn, acts as cytosolic sensors of microbial and self-derived molecules and forms an immune complex called inflammasome in the context of inflammatory commitments. NLRP3 inflammasome assembly is triggered by extracellular ATP, reactive oxygen species (ROS), potassium efflux, calcium misbalance, and lysosome disruption. Due to its involvement in multiple diseases, NLRP3 has become one of the most studied pattern-recognition receptors (PRRs). Nevertheless, the role of NLRP3 in fibrosis development has not been completely elucidated. In this review, we described the relation of the previously mentioned fibrosis pathway with the NLRP3 inflammasome complex formation, especially EMT-related pathways. For now, it is suggested that the EMT happens independently from the oligomerization of the whole inflammasome complex, requiring just the presence of the NLRP3 receptor and the ASC protein to trigger the EMT events, and we will present different pieces of research that give controversial point of views. Frontiers Media S.A. 2020-05-20 /pmc/articles/PMC7251178/ /pubmed/32508821 http://dx.doi.org/10.3389/fimmu.2020.00883 Text en Copyright © 2020 Alyaseer, de Lima and Braga. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Alyaseer, Amani Abraheem Alsadiq
de Lima, Murilo Henrique Saturnino
Braga, Tarcio Teodoro
The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title_full The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title_fullStr The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title_full_unstemmed The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title_short The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
title_sort role of nlrp3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251178/
https://www.ncbi.nlm.nih.gov/pubmed/32508821
http://dx.doi.org/10.3389/fimmu.2020.00883
work_keys_str_mv AT alyaseeramaniabraheemalsadiq theroleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis
AT delimamurilohenriquesaturnino theroleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis
AT bragatarcioteodoro theroleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis
AT alyaseeramaniabraheemalsadiq roleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis
AT delimamurilohenriquesaturnino roleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis
AT bragatarcioteodoro roleofnlrp3inflammasomeactivationintheepithelialtomesenchymaltransitionprocessduringthefibrosis